7WSL
PD-1 in complex with Dostarlimab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 5C (4A) |
Synchrotron site | PAL/PLS |
Beamline | 5C (4A) |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-11-30 |
Detector | DECTRIS EIGER X 9M |
Wavelength(s) | 0.97949 |
Spacegroup name | P 1 |
Unit cell lengths | 39.600, 44.870, 76.960 |
Unit cell angles | 93.80, 98.18, 97.95 |
Refinement procedure
Resolution | 28.543 - 1.534 |
R-factor | 0.1615 |
Rwork | 0.161 |
R-free | 0.17830 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5ggs |
Data reduction software | XDS |
Data scaling software | HKL-2000 |
Phasing software | REFMAC |
Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 28.543 | 1.590 |
High resolution limit [Å] | 1.530 | 1.530 |
Number of reflections | 73835 | 7304 |
<I/σ(I)> | 14.5 | |
Completeness [%] | 95.3 | |
Redundancy | 3.7 | |
CC(1/2) | 0.997 | 0.945 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.2M trimethylamine N-oxide dihydrate, 0.1M Tris pH 8.5, 20% w/v PEG 3350 |